Takeshi Johkoh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Takeshi Johkoh has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Kiminori Fujimoto
Department of Radiology, Kurume University School of Medicine, Kurume, Japan
5 shared publications - Hiromitsu Sumikawa
Department of Radiology, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan
3 shared publications - Hiroto Hatabu
Center for Pulmonary Functional Imaging, Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
3 shared publications - Taiki Fukuda
Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan
3 shared publications - Yasuhiro Kondoh
Department of Respiratory Medicine and Allergology, Aichi Medical University, 1-1 Yazako Karimata, Nagakute, Aichi, 480-1195, Japan; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 160, Nishi-oiwake-cho, Seto, Aichi, 489-8642, Japan
3 shared publications - Yoshiaki Zaizen
Division of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
3 shared publications
Latest Publications
- Open Access
- 10 October 2025
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 44 (2) , 291-302
Volume histogram analysis of whole-lung CT: differentiating usual from nonspecific interstitial pneumonias and predicting prognosis
Purpose: Low agreements among experts for differentiating usual interstitial pneumonia (UIP) from nonspecific interstitial pneumonia (NSIP) motivate the use of automated imaging diagnosis. Volume histogram analysis (VHA) of the lung parenchyma using computer-aided diagnostic software is more straightforward to perform and interpret than radiomics. To assess whether a predictive model generated by VHA (VHA model), using voxel data of each lung lobe obtained via whole-lung CT, can differentiate radiological UIP from NSIP, and to explore the relationship between VHA model outcomes and patient prognosis. Materials and methods: This study included 74 patients from one university hospital (cohort A: 47 patients with idiopathic pulmonary fibrosis [IPF]/UIP and 27 with idiopathic NSIP [iNSIP] and connective tissue disease-associated NSIP [CTD-NSIP]) and 146 patients from another hospital (cohort B: 111 with IPF/UIP and 35 with iNSIP/CTD-NSIP), with diagnoses confirmed through multidisciplinary discussion. Using the VHA values obtained from each lung lobe in cohort A, a formula-based VHA model was developed. The regularization parameters were optimized using five-fold cross-validation to maximize the area under the receiver operating characteristic curve (AUC). This VHA model was externally validated in cohort B. The correlation between various parameters and prognosis was analyzed using Cox proportional hazards multivariate analysis. Results: The mean AUC of the best VHA model that differentiated UIP patterns in cohort A was 0.91 (95% confidence interval [CI], 0.84–0.98), with a positive predictive value (PPV) of 0.97 (0.88–1.00). External validation of this model for cohort B revealed that the AUC for UIP differentiation was 0.81 (0.70–0.88), with a PPV of 0.94 (0.88–0.98). Multivariate analysis revealed that the values calculated by the VHA model were correlated with prognosis (hazard ratio, 1.60; 95% CI, 1.17–2.18; p = 0.003). Conclusion: The VHA model could effectively differentiate radiological UIP patterns and may help predict the prognosis of patients with interstitial pneumonia. Secondary A formula-based model using CT volume histogram analysis (VHA) of each lung lobe was developed to differentiate usual interstitial pneumonia (UIP) from nonspecific interstitial pneumonia (NSIP). The VHA model demonstrated strong diagnostic performance, achieving an area under the curve of 0.81 in external validation, and also statistically correlated with patient prognosis.
- 10 October 2025
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 44 (2) , 291-302
Open AccessVolume histogram analysis of whole-lung CT: differentiating usual from nonspecific interstitial pneumonias and predicting prognosis
Purpose: Low agreements among experts for differentiating usual interstitial pneumonia (UIP) from nonspecific interstitial pneumonia (NSIP) motivate the use of automated imaging diagnosis. Volume histogram analysis (VHA) of the lung parenchyma using computer-aided diagnostic software is more straightforward to perform and interpret than radiomics. To assess whether a predictive model generated by VHA (VHA model), using voxel data of each lung lobe obtained via whole-lung CT, can differentiate radiological UIP from NSIP, and to explore the relationship between VHA model outcomes and patient prognosis. Materials and methods: This study included 74 patients from one university hospital (cohort A: 47 patients with idiopathic pulmonary fibrosis [IPF]/UIP and 27 with idiopathic NSIP [iNSIP] and connective tissue disease-associated NSIP [CTD-NSIP]) and 146 patients from another hospital (cohort B: 111 with IPF/UIP and 35 with iNSIP/CTD-NSIP), with diagnoses confirmed through multidisciplinary discussion. Using the VHA values obtained from each lung lobe in cohort A, a formula-based VHA model was developed. The regularization parameters were optimized using five-fold cross-validation to maximize the area under the receiver operating characteristic curve (AUC). This VHA model was externally validated in cohort B. The correlation between various parameters and prognosis was analyzed using Cox proportional hazards multivariate analysis. Results: The mean AUC of the best VHA model that differentiated UIP patterns in cohort A was 0.91 (95% confidence interval [CI], 0.84–0.98), with a positive predictive value (PPV) of 0.97 (0.88–1.00). External validation of this model for cohort B revealed that the AUC for UIP differentiation was 0.81 (0.70–0.88), with a PPV of 0.94 (0.88–0.98). Multivariate analysis revealed that the values calculated by the VHA model were correlated with prognosis (hazard ratio, 1.60; 95% CI, 1.17–2.18; p = 0.003). Conclusion: The VHA model could effectively differentiate radiological UIP patterns and may help predict the prognosis of patients with interstitial pneumonia. Secondary A formula-based model using CT volume histogram analysis (VHA) of each lung lobe was developed to differentiate usual interstitial pneumonia (UIP) from nonspecific interstitial pneumonia (NSIP). The VHA model demonstrated strong diagnostic performance, achieving an area under the curve of 0.81 in external validation, and also statistically correlated with patient prognosis.
- 5 July 2025
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 46 (4) , 265
Letter From the Guest Editor
- 5 July 2025
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 46 (4) , 265
Letter From the Guest Editor
- 22 June 2025
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 46 (4) , 296-300
Imaging of Pulmonary Benign Lymphoproliferative Disorders
- 22 June 2025
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 46 (4) , 296-300
Imaging of Pulmonary Benign Lymphoproliferative Disorders
- Open Access
- 8 March 2025
- Published by Elsevier in Regenerative Therapy
- Vol. 29, 35-42
Clinical efficacy of invimestrocel for acute respiratory distress syndrome caused by pneumonia: Comparison with historical data using propensity score analysis
- 8 March 2025
- Published by Elsevier in Regenerative Therapy
- Vol. 29, 35-42
Open AccessClinical efficacy of invimestrocel for acute respiratory distress syndrome caused by pneumonia: Comparison with historical data using propensity score analysis
- Open Access
- 14 May 2024
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 42 (9) , 993-1002
Idiopathic dendriform pulmonary ossification as the phenotype of interstitial lung abnormalities: CT–pathologic correlation and prevalence
Background and purpose: Idiopathic dendriform pulmonary ossification (DPO) is mostly asymptomatic, and detected incidentally in lung CT. There have been no reports on the precise CT–pathologic correlation and the prevalence of idiopathic DPO. This study aimed to clarify the histological background and prevalence of idiopathic DPO. Materials and methods: Sixteen patients with histologically confirmed idiopathic DPO (12 men and 4 women; mean age, 38.8 years; range 22–56 years) were identified in a nationwide epidemiological survey. Local HRCT findings of pre-biopsy examinations, such as branching, round, linear structures with or without high attenuation were compared side by side with histological findings. The attenuation of branching, round, and linear structures was classified into three-point levels on bone window images (width, 2500 HU; level, 500 HU). Furthermore, we collected continuous pulmonary CT images of 8111 cases for checking up metastasis from extrathoracic malignancy at a single institution, and evaluated the prevalence of interstitial lung abnormalities (ILAs) and DPO. Results: In all 16 cases, branching (n = 15, 93%), round (n = 5, 31%), or linear (n = 5, 31%) structures were identified, histologically corresponding to dendriform ossification and cicatricial organizing pneumonia (OP)/fibrosis. Histologically, ossification was confirmed in all the 16 patients. However, in two cases, a highly attenuated structure could not be detected on the pre-biopsy CT of the same area. Regarding the prevalence of idiopathic DPO, 283 (3.5%) of 8111 patients had ILAs, of which a total of 26 (0.3% of all cases, 9.2% of ILAs cases) had DPO. Conclusion: Idiopathic DPO showed linear or branching structures with or without high attenuation on CT, corresponded to ossification, cicatricial OP/fibrosis. DPO was seen in 9.2% of ILAs cases. Idiopathic DPO is one of pathologic phenotypes of ILAs.
- 14 May 2024
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 42 (9) , 993-1002
Open AccessIdiopathic dendriform pulmonary ossification as the phenotype of interstitial lung abnormalities: CT–pathologic correlation and prevalence
Background and purpose: Idiopathic dendriform pulmonary ossification (DPO) is mostly asymptomatic, and detected incidentally in lung CT. There have been no reports on the precise CT–pathologic correlation and the prevalence of idiopathic DPO. This study aimed to clarify the histological background and prevalence of idiopathic DPO. Materials and methods: Sixteen patients with histologically confirmed idiopathic DPO (12 men and 4 women; mean age, 38.8 years; range 22–56 years) were identified in a nationwide epidemiological survey. Local HRCT findings of pre-biopsy examinations, such as branching, round, linear structures with or without high attenuation were compared side by side with histological findings. The attenuation of branching, round, and linear structures was classified into three-point levels on bone window images (width, 2500 HU; level, 500 HU). Furthermore, we collected continuous pulmonary CT images of 8111 cases for checking up metastasis from extrathoracic malignancy at a single institution, and evaluated the prevalence of interstitial lung abnormalities (ILAs) and DPO. Results: In all 16 cases, branching (n = 15, 93%), round (n = 5, 31%), or linear (n = 5, 31%) structures were identified, histologically corresponding to dendriform ossification and cicatricial organizing pneumonia (OP)/fibrosis. Histologically, ossification was confirmed in all the 16 patients. However, in two cases, a highly attenuated structure could not be detected on the pre-biopsy CT of the same area. Regarding the prevalence of idiopathic DPO, 283 (3.5%) of 8111 patients had ILAs, of which a total of 26 (0.3% of all cases, 9.2% of ILAs cases) had DPO. Conclusion: Idiopathic DPO showed linear or branching structures with or without high attenuation on CT, corresponded to ossification, cicatricial OP/fibrosis. DPO was seen in 9.2% of ILAs cases. Idiopathic DPO is one of pathologic phenotypes of ILAs.
- Open Access
- 15 November 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (22) , 7100
Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease
Periostin was investigated as a biomarker for rheumatoid arthritis-associated interstitial lung disease (RA-ILD). This prospective study measured serum monomeric and total periostin, Klebs von den Lungen-6 (KL-6), surfactant protein D (SP-D), and lactate dehydrogenase (LDH) in 19 patients with RA-ILD, 20 RA without ILD, and 137 healthy controls (HC). All biomarkers were higher in RA-ILD than HC or RA without ILD. KL-6 accurately detected ILD in RA patients (area under curve [AUC] = 0.939) and moderately detected SP-D and monomeric and total periostin (AUC = 0.803, =0.767, =0.767, respectively). Monomeric and total periostin were negatively correlated with normal lung area and positively correlated with honeycombing, reticulation, fibrosis score, and the traction bronchiectasis grade but not inflammatory areas. Serum levels of SP-D, KL-6, and LDH did not correlate with the extent of those fibrotic areas on high-resolution CT. Serum monomeric and total periostin were higher in patients with RA-ILD with definite usual interstitial pneumonia pattern compared with other ILD patterns. Immunohistochemical analyses of biopsy or autopsy lung tissues from RA-ILD during the chronic phase and acute exacerbation showed that periostin was expressed in fibroblastic foci but not inflammatory or dense fibrosis lesions. Periostin is a potential biomarker for diagnosis, evaluating fibrosis, and deciding therapeutic strategies for patients with RA-ILD.
- 15 November 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (22) , 7100
Open AccessPeriostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease
Periostin was investigated as a biomarker for rheumatoid arthritis-associated interstitial lung disease (RA-ILD). This prospective study measured serum monomeric and total periostin, Klebs von den Lungen-6 (KL-6), surfactant protein D (SP-D), and lactate dehydrogenase (LDH) in 19 patients with RA-ILD, 20 RA without ILD, and 137 healthy controls (HC). All biomarkers were higher in RA-ILD than HC or RA without ILD. KL-6 accurately detected ILD in RA patients (area under curve [AUC] = 0.939) and moderately detected SP-D and monomeric and total periostin (AUC = 0.803, =0.767, =0.767, respectively). Monomeric and total periostin were negatively correlated with normal lung area and positively correlated with honeycombing, reticulation, fibrosis score, and the traction bronchiectasis grade but not inflammatory areas. Serum levels of SP-D, KL-6, and LDH did not correlate with the extent of those fibrotic areas on high-resolution CT. Serum monomeric and total periostin were higher in patients with RA-ILD with definite usual interstitial pneumonia pattern compared with other ILD patterns. Immunohistochemical analyses of biopsy or autopsy lung tissues from RA-ILD during the chronic phase and acute exacerbation showed that periostin was expressed in fibroblastic foci but not inflammatory or dense fibrosis lesions. Periostin is a potential biomarker for diagnosis, evaluating fibrosis, and deciding therapeutic strategies for patients with RA-ILD.
- Open Access
- 22 August 2023
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 14 (1) , 1-13
Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy–controlled, phase 2 multicenter study (ONE-BRIDGE)
Background: Acute respiratory distress syndrome (ARDS) is a life-threatening inflammatory lung injury with high mortality; no approved medication exists. Efficacy and safety of bone marrow–derived, allogeneic, multipotent adult progenitor cells (invimestrocel) plus standard treatment in patients with ARDS caused by pneumonia was evaluated. Methods: A randomized, open-label, standard therapy–controlled, phase 2 study (January 2019–September 2021) conducted in 29 centers in Japan. Patients with ARDS caused by pneumonia, with extensive early fibroproliferation on high-resolution computed tomography and low risk of systemic organ failure identified by an Acute Physiology and Chronic Health Evaluation (APACHE II) score were included. Patients were randomized 2:1 to receive a single intravenous infusion of 9.0 × 108 cells of invimestrocel (administered at a rate of up to 10 mL/min over 30–60 min by free flow) plus standard treatment (N = 20) or standard treatment (N = 10) consistent with the clinical practice guidelines of the Japanese Respiratory Society for the management of ARDS. Primary endpoint was ventilator-free days (VFDs) through day 28 after study treatment. Analysis of covariance was performed with treatment group, age, partial pressure arterial oxygen/fraction of inspired oxygen ratio, and APACHE II score as covariates. Results: Median (interquartile range) number of VFDs was numerically higher in the invimestrocel group versus standard group (20.0 [0.0–24.0] vs 11.0 [0.0–14.0]) but was not statistically significantly different (least square [LS] means [95% confidence interval (CI)]: invimestrocel group, 11.6 [6.9–16.3]; standard group, 6.2 [− 0.4 to 12.8]; LS mean difference [95% CI], 5.4 [− 1.9 to 12.8]; p = 0.1397). Ventilator weaning rate at day 28 was 65% (13/20) versus 30% (3/10), and mortality rate was 21% (4/19) versus 29% (2/7) at day 28 and 26% (5/19 patients) versus 43% (3/7 patients) at day 180, for the invimestrocel and standard groups, respectively. No allergic or serious adverse reactions were associated with invimestrocel. Conclusions: In Japanese patients with ARDS caused by pneumonia, invimestrocel plus standard treatment resulted in no significant difference in the number of VFDs but may result in improved survival compared with standard treatment. Invimestrocel was well tolerated. Trial registration: ClinicalTrials.gov, Identifier: NCT03807804; January 8, 2019; https://clinicaltrials.gov/ct2/show/NCT03807804.
- 22 August 2023
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 14 (1) , 1-13
Open AccessClinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy–controlled, phase 2 multicenter study (ONE-BRIDGE)
Background: Acute respiratory distress syndrome (ARDS) is a life-threatening inflammatory lung injury with high mortality; no approved medication exists. Efficacy and safety of bone marrow–derived, allogeneic, multipotent adult progenitor cells (invimestrocel) plus standard treatment in patients with ARDS caused by pneumonia was evaluated. Methods: A randomized, open-label, standard therapy–controlled, phase 2 study (January 2019–September 2021) conducted in 29 centers in Japan. Patients with ARDS caused by pneumonia, with extensive early fibroproliferation on high-resolution computed tomography and low risk of systemic organ failure identified by an Acute Physiology and Chronic Health Evaluation (APACHE II) score were included. Patients were randomized 2:1 to receive a single intravenous infusion of 9.0 × 108 cells of invimestrocel (administered at a rate of up to 10 mL/min over 30–60 min by free flow) plus standard treatment (N = 20) or standard treatment (N = 10) consistent with the clinical practice guidelines of the Japanese Respiratory Society for the management of ARDS. Primary endpoint was ventilator-free days (VFDs) through day 28 after study treatment. Analysis of covariance was performed with treatment group, age, partial pressure arterial oxygen/fraction of inspired oxygen ratio, and APACHE II score as covariates. Results: Median (interquartile range) number of VFDs was numerically higher in the invimestrocel group versus standard group (20.0 [0.0–24.0] vs 11.0 [0.0–14.0]) but was not statistically significantly different (least square [LS] means [95% confidence interval (CI)]: invimestrocel group, 11.6 [6.9–16.3]; standard group, 6.2 [− 0.4 to 12.8]; LS mean difference [95% CI], 5.4 [− 1.9 to 12.8]; p = 0.1397). Ventilator weaning rate at day 28 was 65% (13/20) versus 30% (3/10), and mortality rate was 21% (4/19) versus 29% (2/7) at day 28 and 26% (5/19 patients) versus 43% (3/7 patients) at day 180, for the invimestrocel and standard groups, respectively. No allergic or serious adverse reactions were associated with invimestrocel. Conclusions: In Japanese patients with ARDS caused by pneumonia, invimestrocel plus standard treatment resulted in no significant difference in the number of VFDs but may result in improved survival compared with standard treatment. Invimestrocel was well tolerated. Trial registration: ClinicalTrials.gov, Identifier: NCT03807804; January 8, 2019; https://clinicaltrials.gov/ct2/show/NCT03807804.
- Open Access
- 12 August 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (32) , e29734
Radiological patterns and prognosis in elderly patients with acute Klebsiella pneumoniae pneumonia: A retrospective study
Although Klebsiella pneumoniae pneumonia is an insidious threat among the elderly, the role of radiological features has not been elucidated. We aimed to evaluate thin-section chest computed tomography (CT) features and assess its associations with disease prognosis in elderly patients with acute K. pneumoniae pneumonia. We retrospectively included elderly patients, admitted for acute K. pneumoniae pneumonia, and investigated thin-section CT findings to determine whether bronchopneumonia or lobar pneumonia was present. The association between the radiological pattern of pneumonia and in-hospital mortality was analyzed. Eighty-six patients with acute K. pneumoniae pneumonia were included, and among them, the bronchopneumonia pattern was observed in 70 (81%) patients. Twenty-five (29%) patients died in hospital, and they had a greater incidence of lobar pneumonia pattern (40% in nonsurvivors vs 10% in survivors; P = .008), low albumin level (2.7 g/dL, range, 1.6–3.8 in nonsurvivors vs 3.0 g/dL, range, 1.7–4.2 in survivors; P = .026) and higher levels of aspartate aminotransferase (30 U/L, range, 11–186 in nonsurvivors vs 23 U/L, range, 11–102 in survivors, P = .017) and C-reactive protein (8.0 mg/dL, range, 0.9–26.5 in nonsurvivors vs 4.7 mg/dL, range, 0.0–24.0 in survivors; P = .047) on admission. Multivariate analysis showed that lobar pneumonia pattern was independently associated with increased in-hospital mortality (adjusted hazard ratio, 3.906; 95% CI, 1.513–10.079; P = .005). In elderly patients with acute K. pneumoniae pneumonia, the lobar pneumonia pattern may be less commonly observed, and this pattern could relate to poor prognosis.
- 12 August 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (32) , e29734
Open AccessRadiological patterns and prognosis in elderly patients with acute Klebsiella pneumoniae pneumonia: A retrospective study
Although Klebsiella pneumoniae pneumonia is an insidious threat among the elderly, the role of radiological features has not been elucidated. We aimed to evaluate thin-section chest computed tomography (CT) features and assess its associations with disease prognosis in elderly patients with acute K. pneumoniae pneumonia. We retrospectively included elderly patients, admitted for acute K. pneumoniae pneumonia, and investigated thin-section CT findings to determine whether bronchopneumonia or lobar pneumonia was present. The association between the radiological pattern of pneumonia and in-hospital mortality was analyzed. Eighty-six patients with acute K. pneumoniae pneumonia were included, and among them, the bronchopneumonia pattern was observed in 70 (81%) patients. Twenty-five (29%) patients died in hospital, and they had a greater incidence of lobar pneumonia pattern (40% in nonsurvivors vs 10% in survivors; P = .008), low albumin level (2.7 g/dL, range, 1.6–3.8 in nonsurvivors vs 3.0 g/dL, range, 1.7–4.2 in survivors; P = .026) and higher levels of aspartate aminotransferase (30 U/L, range, 11–186 in nonsurvivors vs 23 U/L, range, 11–102 in survivors, P = .017) and C-reactive protein (8.0 mg/dL, range, 0.9–26.5 in nonsurvivors vs 4.7 mg/dL, range, 0.0–24.0 in survivors; P = .047) on admission. Multivariate analysis showed that lobar pneumonia pattern was independently associated with increased in-hospital mortality (adjusted hazard ratio, 3.906; 95% CI, 1.513–10.079; P = .005). In elderly patients with acute K. pneumoniae pneumonia, the lobar pneumonia pattern may be less commonly observed, and this pattern could relate to poor prognosis.